World's Best Scientists 2026 revealed!
Oliver A. Cornely

Oliver A. Cornely

Award Badge
Microbiology
Germany
2026

D-Index & Metrics

Microbiology

D-Index
116
Citations
53172
World Ranking
182
National Ranking
11

Medicine

D-Index
116
Citations
53898
World Ranking
4332
National Ranking
237

Research.com Recognitions

  • 2026 - Research.com Microbiology in Germany Leader Award
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Oliver A. Cornely is affiliated with the University of Cologne in Germany and works predominantly in the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Oncology, Pulmonary and Respiratory Medicine, and Small Animals. Their research encompasses several main topics including antifungal resistance and susceptibility, fungal infections and studies, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, infectious diseases and mycology, plant pathogens, and fungal diseases, as well as COVID-19 and healthcare impacts.

Notable recent papers authored or coauthored by Cornely include:

  • Tackling the emerging threat of antifungal resistance to human health (2022), published in Nature Reviews Microbiology
  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (2020), published in The Lancet Infectious Diseases
  • COVID-19 associated pulmonary aspergillosis (2020), published in Mycoses
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion (2020), published in Intensive Care Medicine
  • COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment (2020), published in Journal of Fungi

Cornely frequently collaborates with other researchers, including:

  • Jon Salmanton-García
  • Philipp Koehler
  • Jannik Stemler
  • Martin Hoenigl
  • Rosanne Sprute

Their work is frequently published in several scientific venues, such as:

  • Mycoses
  • Open Forum Infectious Diseases
  • SSRN Electronic Journal
  • HemaSphere
  • The Lancet Infectious Diseases

Oliver A. Cornely has contributed to book publications including one titled Infection Management in Hematology, published by Springer International Publishing in 2020.

Among awards received, Cornely is a Fellow of the European Confederation of Medical Mycology (ECMM).

Best Publications

  • Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

    Oliver A. Cornely;Johan Maertens;Drew J. Winston;John Perfect

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

    Thomas J Walsh;Hedy Teppler;Gerald R Donowitz;Johan A Maertens

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

    Oliver A Cornely;Derrick W Crook;Roberto Esposito;André Poirier

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    Mark H. Wilcox;Dale N. Gerding;Ian R. Poxton;Ciaran Kelly

  • Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

    Ernst-Ruediger Kuse;Ploenchan Chetchotisakd;Clovis Arns da Cunha;Markus Ruhnke

  • Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi

  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    J Maertens;O Marchetti;R Herbrecht;O A Cornely

  • Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

    Stuart Johnson;Thomas J. Louie;Dale N. Gerding;Oliver A. Cornely

  • Combination antifungal therapy for invasive aspergillosis a randomized trial

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

  • COVID-19 associated pulmonary aspergillosis.

    Philipp Koehler;Oliver A. Cornely;Bernd W. Böttiger;Fabian Dusse

  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    M.C. Arendrup;T. Boekhout;T. Boekhout;T. Boekhout;M. Akova;J.F. Meis

  • Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

    Oliver A. Cornely;Mark A. Miller;Thomas J. Louie;Derrick W. Crook;Derrick W. Crook

  • ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    A.M. Tortorano;M. Richardson;E. Roilides;A. van Diepeningen

  • Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients

    Georg Maschmeyer;Antje Haas;Oliver A Cornely

Frequent Co-Authors

Martin Hoenigl
Martin Hoenigl University of California, San Diego
Werner J. Heinz
Werner J. Heinz Caritas-Krankenhaus Bad Mergentheim
Philipp Koehler
Philipp Koehler Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Hilmar Wisplinghoff
Hilmar Wisplinghoff University of Cologne
Jörg J. Vehreschild
Jörg J. Vehreschild University of Cologne
Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
Jacques F. Meis
Jacques F. Meis Canisius-Wilhelmina Ziekenhuis
Axel Hamprecht
Axel Hamprecht University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, pursuing related online degrees can open diverse career opportunities within healthcare and research. Programs like online health information management degree programs cahiim accredited provide essential skills to manage patient data and health records efficiently, aligning well with microbiology’s analytical focus.

Additionally, specialized certifications such as the best fastest online medical billing and coding certificate programs offer quick entry into the healthcare billing sector, a valuable pathway for those seeking flexibility alongside scientific knowledge.

While microbiology itself is largely lab-oriented, exploring what medical degree can i get online helps students understand the broader medical education landscape and the extent of online options available in medicine.

For those interested in public health, pursuing online mph programs easy to get into can complement microbiology studies by focusing on disease prevention and health promotion at the population level.

Best Scientists Citing Oliver A. Cornely

Trending Scientists

Recently Published Articles